|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Short-term investments | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Operating lease right-of-use assets, net | ||||
| Property and equipment, net | ||||
| Long-term investments | ||||
| Restricted cash | ||||
| Other non-current assets | ||||
| Total assets | ||||
| Liabilities, and Stockholders' Equity | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Accrued liabilities | ||||
| Operating lease liability, current portion | ||||
| Other current liabilities | ||||
| Total current liabilities | ||||
| Other non-current liabilities | ||||
| Operating lease liability, non-current portion | ||||
| Financing lease liability | ||||
| Total liabilities | ||||
| Convertible preferred stock: $0.0001 par value -10,000,000 and 157,657,729 shares authorized at December 31, 2025 and December 31, 2024, and 0 and 116,716,142 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively, (liquidation preference $0 and $210,328 at December 31, 2025 and December 31, 2024, respectively) | ||||
| Stockholders' equity: | ||||
| Common stock, par value $0.0001 - 500,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 36,281,767 and 31,524,093 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total stockholders' equity | ||||
| Total liabilities and stockholders' equity |
Loading...
